Clinical trials
Completed Nervous System Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 4 |
| University of British Columbia | 3 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| PTC Therapeutics | 2 |
| University Health Network, Toronto | 2 |
| University of Saskatchewan | 2 |
| Abcuro, Inc. | 1 |
| Baxalta now part of Shire | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 36 |
| Central Nervous System Diseases | 16 |
| Brain Diseases | 13 |
| Neurodegenerative Diseases | 8 |
| Cerebrovascular Disorders | 7 |
| Neuromuscular Diseases | 6 |
| Vascular Diseases | 6 |
| Brain Ischemia | 5 |
| Cardiovascular Diseases | 5 |
| Mental Disorders | 5 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.